psoriasis
PSORIASIS

Psoriasis is a systemic chronic skin disorder characterized by excessive keratinocyte proliferation that results into thickened scaly plaques, itching and inflammatory changes in the epidermis and dermis. It is transmitted genetically but can be provoked by environmental factors.
It is found in approximately 2% of the population that primarily affects the skin and joints.
It is associated with other inflammatory disorders and autoimmune diseases (eg psoriatic arthritis, inflammatory bowel disease, coronary artery disease).
Generally, it begins as red scaling papules that coalesce to form round-to-oval plaques. The rashes are often pruritic and may be painful.

Psoriasis Patient Education

Patient Education

  • Patient and family education is the key to successful management
  • Patient should understand that psoriasis is a chronic disease and treatment will only control the symptoms but not cure it
  • Assure patient that psoriasis is quite common and not contagious
  • Discuss various therapeutic options, risks and benefits, side effects and expected results
    • Emphasize the importance of adherence to treatment
  • Discuss possible exacerbating factors
    • Medications: Beta blockers, Lithium, antimalarials
    • Bacterial or viral infections
  • Encourage a healthy lifestyle
    • Regular exercise
    • Maintain ideal body weight (BMI of 18.5-24.9)
    • No to mild alcohol consumption
    • Smoking cessation
  • Patients with any type of psoriasis should be informed of a potential increased risk for coronary artery disease
  • Advise patients to follow up yearly especially for the 1st 10 years from initial diagnosis
Editor's Recommendations
Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 3 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.